EGFR and non-small cell lung carcinoma: Many randomized and controlled trials of EGFR inhibitors combined with chemotherapeutic drugs have been conducted for the treatment of NSCLC; however, these combinations did not show definitely curative advantages compared with single drug treatments 13-15.